Chia-Hung Lee

Title: Innovations of Chia-Hung Lee

Introduction

Chia-Hung Lee is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of nanoparticle synthesis and drug delivery systems. With a total of 2 patents, his work showcases innovative approaches to enhancing bioavailability and controlled release of bioactive compounds.

Latest Patents

Chia-Hung Lee's latest patents include a method for synthesizing ligand-conjugated gold nanoparticles. This method involves several steps, including the use of amine-modified silica particles and the adsorption of gold ions. The process culminates in the creation of bare gold nanoparticles that can be further modified with ligands. Another significant patent focuses on a charged mesoporous silica nanoparticle-based drug delivery system. This system is designed for controlled release and enhanced bioavailability of negatively charged bioactive compounds, utilizing a positively charged silica matrix with functional groups that facilitate sustained drug release.

Career Highlights

Chia-Hung Lee is affiliated with the National Health Research Institutes, where he applies his expertise in nanoparticle technology to advance health-related research. His innovative work has the potential to impact various fields, including medicine and pharmaceuticals.

Collaborations

Chia-Hung Lee has collaborated with notable colleagues such as Chung-Shi Yang and Leu-Wei Lo. These collaborations have likely contributed to the development and refinement of his innovative patents.

Conclusion

Chia-Hung Lee's contributions to nanoparticle synthesis and drug delivery systems highlight his role as a leading inventor in his field. His patents reflect a commitment to advancing technology for improved health outcomes.